Goldman-Sachs-Group

Filing Details

13F-HR/A • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
Manager Name
Goldman-Sachs-Group
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions • $470.7B total value
Manager:
Search and click to pin securities to the top
Page 239 of 253
Kezar Life Sciences, Inc.
Shares:28.2K
Value:$137.5K
% of Portfolio:0.0% ($137.5K/$470.7B)
STEM, INC.
Shares:392.2K
Value:$137.4K
% of Portfolio:0.0% ($137.4K/$470.7B)
Agora, Inc.
Shares:33.8K
Value:$135.9K
% of Portfolio:0.0% ($135.9K/$470.7B)
MAMMOTH ENERGY SERVICES, INC.
Shares:66.6K
Value:$135.8K
% of Portfolio:0.0% ($135.8K/$470.7B)
Quest Resource Holding Corp
Shares:52.0K
Value:$135.2K
% of Portfolio:0.0% ($135.2K/$470.7B)
ATAI Life Sciences N.V.
Shares:98.6K
Value:$134.2K
% of Portfolio:0.0% ($134.2K/$470.7B)
91854V206
Shares:24.7K
Value:$133.0K
% of Portfolio:0.0% ($133.0K/$470.7B)
G2952X146
Shares:113.6K
Value:$132.9K
% of Portfolio:0.0% ($132.9K/$470.7B)
Oncology Institute, Inc.
Shares:115.1K
Value:$131.3K
% of Portfolio:0.0% ($131.3K/$470.7B)
Caesarstone Ltd.
Shares:53.9K
Value:$130.9K
% of Portfolio:0.0% ($130.9K/$470.7B)
Traeger, Inc.
Shares:77.0K
Value:$129.4K
% of Portfolio:0.0% ($129.4K/$470.7B)
Lucid Diagnostics Inc.
Shares:86.3K
Value:$128.6K
% of Portfolio:0.0% ($128.6K/$470.7B)
BlackRock TCP Capital Corp.
Shares:16.0K
Value:$128.2K
% of Portfolio:0.0% ($128.2K/$470.7B)
ATOSSA THERAPEUTICS, INC.
Shares:187.9K
Value:$126.5K
% of Portfolio:0.0% ($126.5K/$470.7B)
Outlook Therapeutics, Inc.
Shares:103.5K
Value:$126.3K
% of Portfolio:0.0% ($126.3K/$470.7B)
Nine Energy Service, Inc.
Shares:111.7K
Value:$126.2K
% of Portfolio:0.0% ($126.2K/$470.7B)
Artiva Biotherapeutics, Inc.
Shares:42.0K
Value:$125.9K
% of Portfolio:0.0% ($125.9K/$470.7B)
Osisko Development Corp.
Shares:84.5K
Value:$125.8K
% of Portfolio:0.0% ($125.8K/$470.7B)
SAGA COMMUNICATIONS INC
Shares:10.0K
Value:$125.0K
% of Portfolio:0.0% ($125.0K/$470.7B)
GYRE THERAPEUTICS, INC.
Shares:16.1K
Value:$124.7K
% of Portfolio:0.0% ($124.7K/$470.7B)